These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23508783)

  • 1. Challenges associated with widespread use of newer oral anticoagulants in the United States.
    Kaur A; Lee K
    Clin Appl Thromb Hemost; 2014 Jan; 20(1):104-5. PubMed ID: 23508783
    [No Abstract]   [Full Text] [Related]  

  • 2. Dabigatran "non-inferior" to warfarin, but only just.
    BMJ; 2013 Feb; 346():f1219. PubMed ID: 23447339
    [No Abstract]   [Full Text] [Related]  

  • 3. What is the optimum duration of anticoagulation for the management of patients with idiopathic deep venous thrombosis and pulmonary embolism?
    Hyers TM; Shetty HG; Campbell IA
    J R Coll Physicians Edinb; 2010 Sep; 40(3):224-8. PubMed ID: 21127767
    [No Abstract]   [Full Text] [Related]  

  • 4. Recurrent venous thromboembolism: quite harmless after all?
    Konstantinides SV
    Thromb Haemost; 2008 Apr; 99(4):655-6. PubMed ID: 18392321
    [No Abstract]   [Full Text] [Related]  

  • 5. Superficial phlebitis and phase 3.5 trials.
    Goldman L; Ginsberg J
    N Engl J Med; 2010 Sep; 363(13):1278-80. PubMed ID: 20860511
    [No Abstract]   [Full Text] [Related]  

  • 6. [Deep venous thrombosis and pulmonary embolism. Prophylaxis and therapy].
    Beyer J; Schellong S
    Herz; 2005 May; 30(3):204-11. PubMed ID: 15902371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged acenocoumarol treatment in patients with venous thromboembolic disease from a rural area.
    Calvo-Romero JM
    South Med J; 2007 Jul; 100(7):725. PubMed ID: 17639755
    [No Abstract]   [Full Text] [Related]  

  • 8. [Strategies for utilization of anticoagulants in pulmonary embolism].
    Fartoukh M; Simonneau G
    Rev Mal Respir; 1999 Nov; 16(5 Pt 2):949-60. PubMed ID: 10907444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel oral anticoagulants in development: Dabigatran, Rivaroxaban, and Apixaban.
    Sattari M; Lowenthal DT
    Am J Ther; 2011 Jul; 18(4):332-8. PubMed ID: 20535013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulant treatment of deep vein thrombosis and pulmonary embolism.
    Tran H; McRae S; Ginsberg J
    Cardiol Clin; 2008 May; 26(2):235-50, vi-vii. PubMed ID: 18406997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reimbursement for outpatient therapy with enoxaparin.
    Dhamecha A; Yaron J
    Case Manager; 2002; 13(5):56-60; quiz 61. PubMed ID: 12239515
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment of venous thromboembolic disorders: new challenges and opportunities.
    Prandoni P
    Haematologica; 2003 Jun; 88(6):610-3. PubMed ID: 12801835
    [No Abstract]   [Full Text] [Related]  

  • 13. [Low molecular weight heparin--a safer anticoagulant in thrombosis and cancer].
    Schulman S
    Lakartidningen; 2004 May; 101(19):1712-5. PubMed ID: 15188585
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clexane in prevention of acute venous thrombosis and pulmonary thromboembolism].
    Kirienko AI; Zolotukhin IA
    Ter Arkh; 1998; 70(11):78-80. PubMed ID: 9949471
    [No Abstract]   [Full Text] [Related]  

  • 15. The treatment of deep venous thrombosis, including the newer agents.
    Rectenwald JE; Wakefield TW
    Dis Mon; 2005; 51(2-3):104-11. PubMed ID: 15900261
    [No Abstract]   [Full Text] [Related]  

  • 16. D-dimer and duration of anticoagulation.
    Mannarino E; Schillaci G
    N Engl J Med; 2007 Jan; 356(4):421; author reply 423. PubMed ID: 17260409
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and economic impact of low-molecular weight heparins in managed care. Introduction.
    Am J Manag Care; 2000 Nov; 6(20 Suppl):S1024-5. PubMed ID: 11484301
    [No Abstract]   [Full Text] [Related]  

  • 18. D-dimer and duration of anticoagulation.
    Glynn RJ; Goldhaber SZ; Ridker PM
    N Engl J Med; 2007 Jan; 356(4):422-3; author reply 423. PubMed ID: 17256206
    [No Abstract]   [Full Text] [Related]  

  • 19. Using anticoagulants.
    Heaton D
    N Z Med J; 2001 Jul; 114(1136):322. PubMed ID: 11548095
    [No Abstract]   [Full Text] [Related]  

  • 20. D-dimer and duration of anticoagulation.
    Pernod G; Sevestre MA; Labarere J
    N Engl J Med; 2007 Jan; 356(4):421; author reply 423. PubMed ID: 17251543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.